🇺🇸 FDA
Patent

US 10800734

Memantine compounds and their preparation and uses thereof

granted A61KA61K31/225A61K31/235

Quick answer

US patent 10800734 (Memantine compounds and their preparation and uses thereof) held by SUNSHINE LAKE PHARMA CO., LTD. expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SUNSHINE LAKE PHARMA CO., LTD.
Grant date
Tue Oct 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/225, A61K31/235, A61K31/27, A61K31/445